Cargando…
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
The chimeric antigen receptor (CAR) plays a dynamic role in targeting tumour-associated antigens in cancer cells. This novel therapeutic discovery combines fragments of monoclonal antibodies with the signalling and co-stimulatory domains that have been modified to its current fourth generation. CAR...
Autores principales: | Chan, Ler Yie, Dass, Sylvia Annabel, Tye, Gee Jun, Imran, Siti A. M., Wan Kamarul Zaman, Wan Safwani, Nordin, Fazlina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024487/ https://www.ncbi.nlm.nih.gov/pubmed/35453554 http://dx.doi.org/10.3390/biomedicines10040804 |
Ejemplares similares
-
MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022) -
Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through
por: Jusop, Amirah Syamimi, et al.
Publicado: (2023) -
Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
por: Loke, Xin Ya, et al.
Publicado: (2021) -
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
por: Gurumoorthy, Narmatha, et al.
Publicado: (2022) -
Stem Cells and Cancer Stem Cells: The Jekyll and Hyde Scenario and Their Implications in Stem Cell Therapy
por: Wan Kamarul Zaman, Wan Safwani, et al.
Publicado: (2021)